Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program-Reference-Cited by-同舟云学术

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program

Published:2016-06 Issue: Volume:5 Page:36-41
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Zhang Yawei,Zhang Feifei,Wang Hui^ORCID,Zhao Chunjiang,Wang Zhanwei,Cao Bin,Du Yan,Feng Xianju,Hu Yunjian,Hu Bijie,Ji Ping,Liu Zhiyong,Liu Yong,Liao Wanzhen,Lu Juan,Sun Hongli,Wang Zhongxin,Xu Xiuli,Xu Xuesong,Yang Qing,Yu Yunsong,Zhang Rong,Zhuo Chao

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference25 articles.

1. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia;Sibila;Respirology,2015

2. Clinical and economic burden of community-acquired pneumonia among adults in Europe;Welte;Thorax,2012

3. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland;Jokinen;Am J Epidemiol,1993

4. Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial;Wunderink;Am J Respir Crit Care Med,2011

5. Trends in antimicrobial susceptibility of Streptococcus pneumoniae in the Tohoku district of Japan: a longitudinal analysis from 1998 to 2007;Suzuki;Tohoku J Exp Med,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MALDI-TOF MS Indirect Beta-Lactamase Detection in Ampicillin-Resistant Haemophilus influenzae;Microorganisms;2023-04-13

2. Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009–2018;Infection and Drug Resistance;2022-08

3. Clinical Benefits and Cost-Effectiveness of Moxifloxacin as Initial Treatment for Community-Acquired Pneumonia: A Meta-Analysis and Economic Evaluation;Clinical Therapeutics;2021-11

4. Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance;Current Topics in Medicinal Chemistry;2021-05-03

5. In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis;Annals of Laboratory Medicine;2021-05-01